Despite the recent confirmation of a new Ebola outbreak in the Democratic Republic of the Congo’s Ituri province—with 246 suspected cases and 65–80 deaths reported as of May 15, 2026, including 13 laboratory-confirmed infections—trader consensus for no pandemic in 2026 remains robust at 92.5%. Official data from Africa CDC and WHO indicate localized transmission driven primarily by the Bundibugyo strain, distinct from the more virulent Zaire species for which effective vaccines and monoclonal antibody treatments exist. Rapid scaling of surveillance, contact tracing, and regional coordination, combined with the outbreak’s confinement to remote and conflict-affected zones near Uganda and South Sudan, aligns with historical patterns where prior DRC outbreaks (including the 16th in 2025) were contained within months at under 100 cases. Key variables that could alter this assessment include accelerated cross-border spread amid ongoing security instability or delayed genomic confirmation of strain-specific countermeasures, with updated WHO situational reports expected within days.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoEbola pandemic in 2026?
Ebola pandemic in 2026?
NUOVO
NUOVO
31 dic 2026
NUOVO
NUOVO
31 dic 2026
This market will resolve to “Yes” if the World Health Organization explicitly characterizes Ebola virus disease, Ebola, any Ebola strain, or any outbreak of ebola as a “pandemic” in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Despite the recent confirmation of a new Ebola outbreak in the Democratic Republic of the Congo’s Ituri province—with 246 suspected cases and 65–80 deaths reported as of May 15, 2026, including 13 laboratory-confirmed infections—trader consensus for no pandemic in 2026 remains robust at 92.5%. Official data from Africa CDC and WHO indicate localized transmission driven primarily by the Bundibugyo strain, distinct from the more virulent Zaire species for which effective vaccines and monoclonal antibody treatments exist. Rapid scaling of surveillance, contact tracing, and regional coordination, combined with the outbreak’s confinement to remote and conflict-affected zones near Uganda and South Sudan, aligns with historical patterns where prior DRC outbreaks (including the 16th in 2025) were contained within months at under 100 cases. Key variables that could alter this assessment include accelerated cross-border spread amid ongoing security instability or delayed genomic confirmation of strain-specific countermeasures, with updated WHO situational reports expected within days.
This market will resolve to “Yes” if the World Health Organization explicitly characterizes Ebola virus disease, Ebola, any Ebola strain, or any outbreak of ebola as a “pandemic” in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Mercato aperto: May 15, 2026, 3:03 PM ET
Volume
$1,329Data di fine
31 dic 2026Mercato aperto
May 15, 2026, 3:03 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if the World Health Organization explicitly characterizes Ebola virus disease, Ebola, any Ebola strain, or any outbreak of ebola as a “pandemic” in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Despite the recent confirmation of a new Ebola outbreak in the Democratic Republic of the Congo’s Ituri province—with 246 suspected cases and 65–80 deaths reported as of May 15, 2026, including 13 laboratory-confirmed infections—trader consensus for no pandemic in 2026 remains robust at 92.5%. Official data from Africa CDC and WHO indicate localized transmission driven primarily by the Bundibugyo strain, distinct from the more virulent Zaire species for which effective vaccines and monoclonal antibody treatments exist. Rapid scaling of surveillance, contact tracing, and regional coordination, combined with the outbreak’s confinement to remote and conflict-affected zones near Uganda and South Sudan, aligns with historical patterns where prior DRC outbreaks (including the 16th in 2025) were contained within months at under 100 cases. Key variables that could alter this assessment include accelerated cross-border spread amid ongoing security instability or delayed genomic confirmation of strain-specific countermeasures, with updated WHO situational reports expected within days.
This market will resolve to “Yes” if the World Health Organization explicitly characterizes Ebola virus disease, Ebola, any Ebola strain, or any outbreak of ebola as a “pandemic” in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a “pandemic.” A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Volume
$1,329Data di fine
31 dic 2026Mercato aperto
May 15, 2026, 3:03 PM ETResolver
0x65070BE91...Despite the recent confirmation of a new Ebola outbreak in the Democratic Republic of the Congo’s Ituri province—with 246 suspected cases and 65–80 deaths reported as of May 15, 2026, including 13 laboratory-confirmed infections—trader consensus for no pandemic in 2026 remains robust at 92.5%. Official data from Africa CDC and WHO indicate localized transmission driven primarily by the Bundibugyo strain, distinct from the more virulent Zaire species for which effective vaccines and monoclonal antibody treatments exist. Rapid scaling of surveillance, contact tracing, and regional coordination, combined with the outbreak’s confinement to remote and conflict-affected zones near Uganda and South Sudan, aligns with historical patterns where prior DRC outbreaks (including the 16th in 2025) were contained within months at under 100 cases. Key variables that could alter this assessment include accelerated cross-border spread amid ongoing security instability or delayed genomic confirmation of strain-specific countermeasures, with updated WHO situational reports expected within days.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti